Company Merrimack Pharmaceuticals Inc Nasdaq
Equities
US5903281005
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ulrik Nielsen
FOU | Founder | 52 | 01/93/01 |
Gary Crocker
CEO | Chief Executive Officer | 72 | 01/04/01 |
Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Crocker
CEO | Chief Executive Officer | 72 | 01/04/01 |
Director/Board Member | 45 | 19/19/19 | |
Ulrik Nielsen
FOU | Founder | 52 | 01/93/01 |
Director/Board Member | 46 | 19/19/19 | |
Ana Radeljevic
BRD | Director/Board Member | 44 | 06/22/06 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 14,788,369 | 14,612,210 ( 98.81 %) | 0 | 98.81 % |
Company contact information
Merrimack Pharmaceuticals, Inc.
One Broadway 14th Floor
02142, Cambridge
+
http://www.merrimackpharma.comSector
1st Jan change | Capi. | |
---|---|---|
+52.36% | 5.81TCr | |
-3.86% | 4.05TCr | |
+36.73% | 3.9TCr | |
-12.01% | 2.66TCr | |
+14.13% | 2.67TCr | |
-21.62% | 1.9TCr | |
+0.21% | 1.22TCr | |
+25.96% | 1.19TCr | |
+23.02% | 1.2TCr |